Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Settles Shareholder Suit Over Enhance Trial
Pharmalot
Wednesday, October 19, 2011 - 10:38am
tags:
Merck, ENHANCE, Vytorin, shareholders, settlements, Schering Plough
Mylan settles lawsuit with Warner Chilcott
Bizjournals.com
Wednesday, October 19, 2011 - 10:37am
tags:
Warner Chilcott, Mylan, Femcon FE, birth control pill, generics
Keryx: Readers React to Perifosine Prediction
TheStreet.com
Wednesday, October 19, 2011 - 9:41am
tags:
Keryx, Perifisone
Abbott Will Split Into Two Companies With Planned Spinoff of Drug Division
Bloomberg
Wednesday, October 19, 2011 - 9:38am
tags:
reorganization, spinoff, Abbott Laboratories
Abbott post 66% drop in profit; plans spin off
Marketwatch
Wednesday, October 19, 2011 - 9:38am
tags:
Abbott Laboratories, earnings, reorganization, spinoff
Elan ‘Just Starting’ May Reward Investors After 10-Year Drop
Bloomberg
Wednesday, October 19, 2011 - 9:37am
tags:
Elan, investors
Dated Information Causes Human Genome To Pop
Seeking Alpha
Tuesday, October 18, 2011 - 7:07pm
tags:
Human Genome Sciences, GSK, M&A, Benlysta, Merck, Biogen Idec
Jazz Pharma To FDA: What Patient Deaths?
Pharmalot
Tuesday, October 18, 2011 - 12:16pm
tags:
FDA, death, Jazz Pharmaceuticals, Xyrem
Bristol-Myers, Sanofi $442 Million Plavix Award Upheld on Appeal
Bloomberg
Tuesday, October 18, 2011 - 12:13pm
tags:
Plavix, Sanofi, Bristol-Myers Squibb, patents
GlaxoSmithKline to Make a Bid for Human Genome Sciences?
Yahoo/Wall St. Cheat Sheet
Tuesday, October 18, 2011 - 12:12pm
tags:
GSK, Human Genome Sciences, M&A
Par acquires three generics from Teva
Drugstore News
Tuesday, October 18, 2011 - 10:40am
tags:
Teva Pharmaceuticals, generics, Par Pharmaceutical, Actiq, Provigil, Amrix
6 Biotech Stocks With A History Of Earnings Surprises
Seeking Alpha
Tuesday, October 18, 2011 - 10:36am
tags:
Array Biopharma, earnings, Aveo Pharmaceutical, Cornerstone Therapeutics, Neuralstem, Immunogen, Jazz Pharmaceuticals
Halozyme rallies on Herceptin drug study
Marketwatch
Tuesday, October 18, 2011 - 10:34am
tags:
Halozyme, Herceptin, Roche, breast cancer
Forest Labs Posts Weak Quarter
TheStreet.com
Tuesday, October 18, 2011 - 10:33am
tags:
earnings, Forest Labs
FDA Panel: Teva Parkinson's Drug Doesn't Slow Disease
NASDAQ.com
Tuesday, October 18, 2011 - 9:26am
tags:
FDA, advisory panels, Teva Pharmaceuticals, Parkinson's Disease, Azilect
Embryonic Stem-Cell Patents Infringe EU Law, Top Court Says
Bloomberg
Tuesday, October 18, 2011 - 9:24am
tags:
embryonic stem cells, Europe, stem cells
Third Rock Ventures launches new biotech, SAGE Therapeutics
Bizjournals.com
Tuesday, October 18, 2011 - 9:23am
tags:
SAGE Therapeutics, Third Rock, CNS
5 Top Birth Control Stocks To Hold As Contraception Skyrockets Due to Recession
Seeking Alpha
Tuesday, October 18, 2011 - 9:01am
tags:
contraceptives, birth control, JNJ, Merck, Pfizer, Teva Pharmaceuticals
J&J Third-Quarter Profit Declines on Generics
Bloomberg
Tuesday, October 18, 2011 - 9:00am
tags:
earnings, generics, JNJ
Astra, Forest to start Phase 3 superbug drug study
Reuters
Tuesday, October 18, 2011 - 8:59am
tags:
AstraZeneca, Forest Labs, CAZ-AVI, antibiotics, superbugs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.